The CEO Corner is intended to provide additional and in-depth perspective to press releases, corporate developments and development pipeline progress.
AN INNOVATIVE TARGETED ONCOLOGY COMPANY BUILT ON NEXT GENERATION ANTIBODY-DRUG CONJUGATES (ADC) AND A NOVEL DISCOVERY ENGINE